Medicines and Healthcare products Regulatory Agency (MHRA) good manufacturing practice data integrity expectations for the pharmaceutical industry.

Good manufacturing practice: data integrity definitions

This file may not be suitable for users of assistive technology.Request a different format.

 

This guidance sets out our expectations for data integrity in good manufacturing practice (GMP).

It complements existing EU GMP guidance and should be read in conjunction with national medicines legislation and the GMP standards published in Eudralex volume 4.

This guidance has been revised following stakeholder feedback. You should send any questions or feedback to gmpinspectorate@mhra.gsi.gov.uk.

 

Posted on the UK MHRA website on 13 March 2015